| Patient | Emily Dickinson |
|---|---|
| Date of birth | 1971-12-10 |
| Identifiers | MRN HR-NI023-SYN; SSN (made up) 000-23-6081 |
| Document date | 2026-01-12 |
| Author | Lucinda Hartwell, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
The patient attends this visit for primary care home visit for headaches, nausea, and tiredness, with raised blood pressure and abnormal kidney tests. [S]
Sodium: 139 mmol/L; Potassium: 4.4 mmol/L; Bicarbonate (total CO2): 24 mmol/L; BUN: 21 mg/dL; Creatinine: 1.2 mg/dL (high); eGFR: 54 mL/min/1.73 m² (low); Glucose: 92 mg/dL; Calcium: 9.3 mg/dL; Phosphate: 3.8 mg/dL; Intact PTH: 74 pg/mL (high); 25-hydroxyvitamin D: 21 ng/mL (low); Albumin: 4.1 g/dL; Hemoglobin: 12.3 g/dL; Total cholesterol: 214 mg/dL (high); HDL cholesterol: 54 mg/dL; LDL cholesterol: 134 mg/dL (high); Triglycerides: 130 mg/dL; HbA1c: 5.5%; TSH: 2.1 mIU/L; Urine albumin-creatinine ratio: 240 mg/g (high); Urine red cells: 1 /[HPF]; KFRE 2-year kidney failure risk: 0.5%; KFRE 5-year kidney failure risk: 1.6%; PHQ-9: 6; GAD-7: 5. [S]
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-01-12 | Body height | 163 | cm | S |
| 2026-01-12 | Body weight | 54 | kg | S |
| 2026-01-12 | Body mass index (BMI) [Ratio] | 20.3 | kg/m2 | S |
| 2026-01-12 | Systolic blood pressure | 166 | mm[Hg] | S |
| 2026-01-12 | Diastolic blood pressure | 98 | mm[Hg] | S |
| 2026-01-12 | Heart rate | 78 | /min | S |
| 2026-01-12 | Respiratory rate | 14 | /min | S |
| 2026-01-12 | Body temperature | 36.6 | Cel | S |
| 2026-01-12 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-01-12 | Sodium [Moles/volume] in Serum or Plasma | 139 | mmol/L | 135-145 mmol/L | Normal | S |
| 2026-01-12 | Potassium [Moles/volume] in Serum or Plasma | 4.4 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 2026-01-12 | Carbon dioxide, total [Moles/volume] in Serum or Plasma | 24 | mmol/L | 22-29 mmol/L | Normal | S |
| 2026-01-12 | Urea nitrogen [Mass/volume] in Serum or Plasma | 21 | mg/dL | 6-21 mg/dL | Normal | S |
| 2026-01-12 | Creatinine [Mass/volume] in Serum or Plasma | 1.2 | mg/dL | 0.59-1.04 mg/dL | High | S |
| 2026-01-12 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M | 54 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Low | S |
| 2026-01-12 | Glucose [Mass/volume] in Serum or Plasma | 92 | mg/dL | 70-99 mg/dL | Normal | S |
| 2026-01-12 | Calcium [Mass/volume] in Serum or Plasma | 9.3 | mg/dL | 8.6-10.3 mg/dL | Normal | S |
| 2026-01-12 | Phosphate [Mass/volume] in Serum or Plasma | 3.8 | mg/dL | 2.5-4.5 mg/dL | Normal | S |
| 2026-01-12 | Parathyrin.intact [Mass/volume] in Serum or Plasma | 74 | pg/mL | 15-65 pg/mL | High | S |
| 2026-01-12 | 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma | 21 | ng/mL | 30-100 ng/mL | Low | S |
| 2026-01-12 | Albumin [Mass/volume] in Serum or Plasma | 4.1 | g/dL | 3.5-5 g/dL | Normal | S |
| 2026-01-12 | Hemoglobin [Mass/volume] in Blood | 12.3 | g/dL | 12-15.5 g/dL | Normal | S |
| 2026-01-12 | Cholesterol [Mass/volume] in Serum or Plasma | 214 | mg/dL | <=199 mg/dL | High | S |
| 2026-01-12 | Cholesterol in HDL [Mass/volume] in Serum or Plasma | 54 | mg/dL | >=50 mg/dL | Normal | S |
| 2026-01-12 | Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation | 134 | mg/dL | <=99 mg/dL | High | S |
| 2026-01-12 | Triglyceride [Mass/volume] in Serum or Plasma | 130 | mg/dL | <=149 mg/dL | Normal | S |
| 2026-01-12 | Hemoglobin A1c/Hemoglobin.total in Blood | 5.5 | % | <=5.6% | Normal | S |
| 2026-01-12 | Thyrotropin [Units/volume] in Serum or Plasma | 2.1 | m[IU]/L | 0.4-4 mIU/L | Normal | S |
| 2026-01-12 | Albumin/Creatinine [Mass Ratio] in Urine | 240 | mg/g | <=30 mg/g | High | S |
| 2026-01-12 | Erythrocytes [#/area] in Urine sediment by Microscopy high power field | 1 | /[HPF] | <=2 /[HPF] | Normal | S |
| 2026-01-12 | Kidney failure 2-year risk [Likelihood] by KFRE | 0.5 | % | S | ||
| 2026-01-12 | Kidney failure 5-year risk [Likelihood] by KFRE | 1.6 | % | S | ||
| 2026-01-12 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 6 | {score} | S | ||
| 2026-01-12 | Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] | 5 | {score} | S |
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Naproxen sodium 220 mg oral tablet, two tablets by mouth as needed for headache (over the counter) | Two tablets as needed, up to twice a day | Oral route | 2025-10-01 to 2026-01-12 | stopped | S |
| Losartan 50 mg oral tablet, one tablet by mouth daily | One tablet by mouth daily | Oral route | 2026-01-12 to 2026-02-02 | completed | S |
| Atorvastatin 20 mg oral tablet, one tablet by mouth daily | One tablet by mouth daily | Oral route | 2026-01-12 | active | S |
| Cholecalciferol (vitamin D3) 25 mcg (1,000 units) oral tablet, one tablet by mouth daily | One tablet by mouth daily | Oral route | 2026-01-12 | active | S |
| Acetaminophen 500 mg oral tablet, two tablets by mouth every 6 hours as needed for headache, no more than 3 g a day | Two tablets every 6 hours as needed; maximum 6 tablets a day | Oral route | 2026-01-12 | active | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Chronic kidney disease stage G3a A2, attributed to hypertension; synthetic modern diagnosis linked to the Bright's disease entered on her death certificate | active | confirmed | N18.31 | S — Synthetic modern diagnosis. Bright's disease as her recorded cause of death is documented (D); what it meant in her case is a retrospective question (R), and no kidney test from her lifetime exists. |
| Hypertension with chronic kidney disease (hypertensive chronic kidney disease, stage 3a); synthetic modern diagnosis linked to the retrospective view that she had severe hypertension | active | confirmed | I12.9 | S — Synthetic modern diagnosis; severe hypertension is a retrospective interpretation (R, possible), and no blood pressure from her lifetime exists. |
| Vitamin D deficiency with a mildly raised PTH in chronic kidney disease | active | confirmed | E55.9 | S — Synthetic laboratory finding at the intake visit. |